BPMC - Blueprint Medicines EPS beats by $0.11 beats on revenue April, 29 2021 07:06 AM Blueprint Medicines Corporation Blueprint Medicines (BPMC): Q1 GAAP EPS of -$1.72 beats by $0.11.Revenue of $21.58M (+249.8% Y/Y) beats by $3.63M.Press Release For further details see: Blueprint Medicines EPS beats by $0.11, beats on revenue